arrow
M

Matteo Morra

university of verona
H指数:5
被引数:219

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the evidence for use of cefiderocol as part of combination therapies: a systematic review of in vitro, in vivo, and clinical studies

探索cefiderocol作为联合疗法一部分的证据:对<em>体外、体内</em>和临床研究的系统综述

2026-10-120
OAAI
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments

宿主免疫反应促进接受单克隆抗体治疗的患者发生SARS-CoV-2突变

2023-03-1521
OAAI
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
2022-11-2210
OA
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study

单克隆抗体治疗SARS-CoV-2突破性感染高危患者的临床影响: ORCHESTRA前瞻性队列研究

2022-08-242
OAAI
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study

不同单克隆抗体方案在疾病进展高危轻中度新型冠状病毒肺炎非住院患者中的临床疗效: 一项前瞻性队列研究

2022-06-215
OAAI